| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-20 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-10 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-08 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.23 | 3e-07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-07 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-07 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |